Skip to main content

Biomarin Pharmaceuticals(BMRN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business

PR Newswire - Mon Feb 27, 2023

Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)

Three Months Ended

December 31,

Twelve Months Ended

December 31,

2022

2021

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe